Skip to content
The Department of Neurology has a long and dynamic legacy of promoting diversity and inclusion in the workplace and health care setting.
Contact our scheduling team to make an in-person or Virtual Visit appointment
Learn about our Adult Neurology and Child Neurology Residency Programs.
Clinical trials are a key component of the research mission of the Department of Neurology at CUIMC
Showing 201 - 210 of 300 results.
By studying centenarians, researchers hope to develop strategies to ward off Alzheimer’s disease and slow brain aging for all of us.
A public battle rages over access to experimental, trial-phase drugs
Race, age, income, and insurance status are all factors in the distance a stroke patient must travel to receive certified care.
Drs. Bell and Ader will conduct a feasibility study titled, "Intervention to capture the diagnostic potential of individuals in a group-based learning or clinical environment."
After her diagnosis of glioblastoma in 2016, she founded an organization that advocated for patients and research.
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
After exercising, choose a brain-healthy recovery meal.
It’s clear the virus can get very close to the brain. What’s less certain is whether virus is able to penetrate deeper and invade it.
Other researchers are not convinced that these biomarkers vary by race, primarily because so little Alzheimer’s research has been conducted on Black and Latinx people.
Lou Gehrig’s worst full season was his best as amyotrophic lateral sclerosis, or ALS, was beginning to erode him from the inside.